• 1
    Brandi ML, Collin-Osdoby P 2006 Vascular biology and the skeleton. J Bone Miner Res 21: 183192.
  • 2
    Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S 2005 Circulating osteoblast-lineage cells in humans. N Engl J Med 352: 19591966.
  • 3
    Kassem M, Risteli L, Mosekilde L, Melsen F, Eriksen EF 1991 Formation of osteoblast-like cells from human mononuclear bone marrow cultures. APMIS 99: 269274.
  • 4
    Fang TD, Salim A, Xia W, Nacamuli RP, Guccione S, Song HM, Carano RA, Filvaroff EH, Bednarski MD, Giaccia AJ, Longaker MT 2005 Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 20: 11141124.
  • 5
    Carvalho RS, Einhorn TA, Lehmann W, Edgar C, Al-Yamani A, Apazidis A, Pacicca D, Clemens TL, Gerstenfeld LC 2004 The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 34: 849861.
  • 6
    Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F 2001 Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16: 15751582.
  • 7
    Qvesel D, Melsen F, Eriksen EF 1999 Paratrabecular endothelial cells as osteoblast precursors: Immunohistochemical description of sinusoidal structure in human bone biopsies. Calcif Tissue Int 64(Suppl): S61.
  • 8
    Qvesel D, Eriksen EF, Melsen F 2005 Formation of paratrabecular sinusoidal structures initiates bone remodeling; Detachment and not retraction of lining cells from the bone surface is the primary event. J Bone Miner Res 14(Suppl): S467.
  • 9
    Qvesel D, Baatrup A, Hauge EM, Melsen F 2005 Different tissue distribution and sequential expression of insulin like growth factor 1 and 2 during bone formation. Immunohistochemical studies of human bone biopsies. Calcif Tissue Int 64: S90.
  • 10
    Eriksen EF, Qvesel D, Hauge EM, Melsen F 2005 Further evidence that vascular remodeling spaces are lined by cells of osteogenic origin: Characterization of a possible coupling structure. J Bone Miner Res 15(Suppl): S371.
  • 11
    Parfitt AM 2001 The bone remodeling compartment: A circulatory function for bone lining cells. J Bone Miner Res 16: 15831585.
  • 12
    Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN 2000 Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2: 477488.
  • 13
    Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG 2001 Circulating skeletal stem cells. J Cell Biol 153: 11331140.
  • 14
    Ralston SH 1997 The Michael Mason Prize Essay 1997. Nitric oxide and bone: What a gas! Br J Rheumatol 36: 831838.
  • 15
    Bushinsky DA 10/2001 Acid-base imbalance and the skeleton. Eur J Nutr 40: 238244.
  • 16
    Goldhaber P, Rabadjija L 1987 H+ stimulation of cell-mediated bone resorption in tissue culture. Am J Physiol 253: E90E98.
  • 17
    Arnett TR, Dempster DW 1986 Effect of pH on bone resorption by rat osteoclasts in vitro. Endocrinology 119: 119124.
  • 18
    Arnett TR, Gibbons DC, Utting JC, Orriss IR, Hoebertz A, Rosendaal M, Meghji S 2003 Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol 196: 28.
  • 19
    Utting JC, Robins SP, Brandao-Burch A, Oriss IR, Behar J, Arnett TR 2006 Hypoxia inhibits the growth, differentiation and bone forming capacity of rat osteoblasts. Exp Cell Res 312: 16941702.
  • 20
    Silvestrini G, Ballanti P, Patacchioli F, Leopizzi M, Gualteri N, Monnazzi P, Tremante E, Sardella D, Bonucci E 2005 Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat. J Molec Histol 36: 5967.
  • 21
    Lapidot T, Dar A, Kollet O 2005 How do stem cells find their way home? Blood 106: 19011910.
  • 22
    Marotti G, Ferretti M, Muglia MA, Palumbo C, Palazzini S 1992 A quantitative evaluation of osteoblast-osteocyte relationships on growing endosteal surface of rabbit tibiae. Bone 13: 363368.
  • 23
    Bonewald LF 2004 Osteocyte biology: Its implications for osteoporosis. J Musculoskeletal Neuronal Interact 4: 101104.
  • 24
    Duncan RL, Turner CH 1995 Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int 57: 344358.
  • 25
    Dobnig H, Turner RT 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136: 36323638.
  • 26
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 14341441.
  • 27
    Eriksen EF, Robins DA 2004 Teriparatide: A bone formation treatment for osteoporosis. Drugs Today 40: 935948.
  • 28
    Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK 2002 Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 277: 39263934.
  • 29
    Mundy GR 1997 Mechanisms of bone metastasis. Cancer 80: 15461556.
  • 30
    Mundy GR, Yoneda T, Hiraga T 2001 Preclinical studies with zoledronic acid and other bisphosphonates: Impact on the bone microenvironment. Semin Oncol 28: 3544.
  • 31
    Kassem M, Mosekilde L, Rungby J, Mosekilde L, Melsen F, Eriksen EF 1991 Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS 99: 262268.
  • 32
    Buckley KA, Chan BY, Fraser WD, Gallagher JA 2005 Human osteoclast culture from peripheral blood monocytes: Phenotypic characterization and quantitation of resorption. Methods Mol Med 107: 5568.
  • 33
    Long MW, Robinson JA, Ashcraft EA, Mann KG 1995 Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest 95: 881887.
  • 34
    Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE 1998 Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13: 828838.
  • 35
    Minasi MG, Riminucci M, De AL, Borello U, Berarducci B, Innocenzi A, Caprioli A, Sirabella D, Baiocchi M, De MR, Boratto R, Jaffredo T, Broccoli V, Bianco P, Cossu G 2002 The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129: 27732783.
  • 36
    Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ 2003 Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 9: 95103.
  • 37
    Veillette CJ, von Schroeder HP 2004 Endothelin-1 down-regulates the expression of vascular endothelial growth factor-A associated with osteoprogenitor proliferation and differentiation. Bone 34: 288296.
  • 38
    Tombran-Tink J, Barnstable CJ 2004 Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: Possible mediators of angiogenesis and matrix remodeling in the bone. Biochem Biophys Res Commun 316: 573579.
  • 39
    Xiong H, Rabie AB 2005 Neovascularization and mandibular condylar bone remodeling in adult rats under mechanical strain. Front Biosci 10: 7482.
  • 40
    Li G, Cui Y, McIlmurray L, Allen WE, Wang H 2005 rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508 induce chemotaxis of human osteoblasts and microvascular endothelial cells. J Orthop Res 23: 680685.
  • 41
    Mayer H, Bertram H, Lindenmaier W, Korff T, Weich H 2005 Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: Autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95: 827839.
  • 42
    Ferrara N 2000 Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55: 1535.
  • 43
    Ferrara N 2005 The role of VEGF in the regulation of physiological and pathological angiogenesis. Experientia Suppl 94: 209231.
  • 44
    Spector JA, Mehrara BJ, Greenwald JA, Saadeh PB, Steinbrech DS, Bouletreau PJ, Smith LP, Longaker MT 2001 Osteoblast expression of vascular endothelial growth factor is modulated by the extracellular microenvironment. Am J Physiol Cell Physiol 280: C72C80.
  • 45
    Min JK, Kim YM, Kim YM, Kim EC, Gho YS, Kang IJ, Lee SY, Kong YY, Kwon YG 2003 Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. J Biol Chem 278: 3954839557.